The United States Patent and Trademark Office (USPTO) has announced changes to trademark fees, all of which will take effect on Jan. 18, 2025, ...
It's hard to get too worked up about bowl outcomes in this day and ... as the truth here is a bit more complicated than the neat, segmented chart you see above. We don't have a clue who DeBoer ...
Five policemen in Farrukhabad, UP were found guilty of falsely implicating a villager by planting a pistol on him. They produced false evidence, leading to the villager's imprisonment. Following a ...
NEW YORK(Reuters) - Jana Partners is working with a sixth executive to push for changes at Lamb Weston, signaling the activist investor may seek to replace the majority of the french fry maker's board ...
“The EMA filing acceptance for blarcamesine ... Marketing Authorization Application is supported by data from the randomized, double-blind, placebo-controlled Phase IIb/III, ANAVEX2-73-AD-004 trial ...
IRS based the amounts that taxpayers received on their income, tax filing status and number of children or qualifying dependents. In March 2020, eligible individuals received up to $1,200 per ...
Daura has filed a filing statement dated effective December ... a minimum of 20,333,334 units (each a "Unit") and a maximum of up to 25,000,000 Units at a price of $0.06 per Unit for gross ...
“The EMA filing acceptance for blarcamesine to review the Marketing Authorization Application potentially brings us a step closer offering broader patient access to a new treatment option in ...
“The EMA filing acceptance for blarcamesine to review the Marketing Authorization Application potentially ... ANAVEX®2-73-AD-004 trial and it’s up to 144 week open-label-extension (OLE ...
Vancouver, British Columbia--(Newsfile Corp. - December 23, 2024) - Daura Capital Corp. (TSXV: DUR.P) (the "Company" or "Daura"), a capital pool company, announced that it has received conditional ...
“The EMA filing acceptance for blarcamesine to review the Marketing Authorization Application potentially brings us a step ... ANAVEX ® 2-73-AD-004 trial and it’s up to 144 week open-label-extension ...